Literature DB >> 11570821

Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast.

M Tresini1, A Lorenzini, L Frisoni, R G Allen, V J Cristofalo.   

Abstract

Replicative senescence is characterized by numerous phenotypic alterations including the loss of proliferative capacity in response to mitogens and numerous changes in gene expression including impaired serum inducibility of the immediate-early genes c-fos and erg-1. Transcription of c-fos in response to mitogens depends on the activation of a multiprotein complex formed on the c-fos serum response element (SRE), which includes the transcription factors SRF (serum response factor) and TCF (ternary complex factor). Our data indicate that at least two defects are responsible for the decreased c-fos transcription in senescent cells, one caused by diminished DNA binding activity of the SRF and another resulting from impaired activation of the TCF, Elk-1. In nuclei isolated from serum stimulated senescent cells the activating phosphorylation of p62(TCF)/Elk-1, which is catalyzed by the members of the extracellular-regulated kinase (ERK) family was strikingly diminished and correlated with a decrease in the abundance of activated ERK proteins. In contrast, in total cell lysates ERK phosphorylation and ERK activity (normalized to total protein) reached similar levels following stimulation of early- and late-passage cells. Interestingly, senescent cells consistently exhibited higher ERK protein abundance. Thus, the proportion of phosphorylated (active) ERK molecules in stimulated senescent cells was lower than in early passage cells. The accumulation of unphosphorylated ERK molecules in senescent cells correlated with the diminished abundance of phosphorylated (active) MEK. These data indicate that in senescent cells there is a general dysregulation in the ERK signaling pathway, which results in the accumulation of inactive ERK molecules, decreased abundance of active ERK in the nucleus of senescent cells, and subsequent lack of activation of the transcription factor TCF(Elk-1). These impairments, together with the impaired DNA binding activity of SRF, could potentially account for the lack of c-fos expression in senescent cells and for multiple other molecular changes dependent upon this pathway. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570821     DOI: 10.1006/excr.2001.5334

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

2.  Proteasome modulates mitochondrial function during cellular senescence.

Authors:  Claudio A Torres; Viviana I Perez
Journal:  Free Radic Biol Med       Date:  2007-10-10       Impact factor: 7.376

3.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

Review 4.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

5.  Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.

Authors:  Laure Voisin; Marc K Saba-El-Leil; Catherine Julien; Christophe Frémin; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

6.  Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets.

Authors:  Sandip K Basu; Sook Lee; Jacqueline Salotti; Srikanta Basu; Krisada Sakchaisri; Zhen Xiao; Vijay Walia; Christopher J Westlake; Deborah K Morrison; Peter F Johnson
Journal:  Cancer Res       Date:  2017-12-19       Impact factor: 12.701

7.  Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells.

Authors:  Elizabeth R Smith; Kathy Qi Cai; Jennifer L Smedberg; Melina M Ribeiro; Malgorzata E Rula; Carolyn Slater; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor.

Authors:  Keith Wheaton; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle.

Authors:  D Williamson; P Gallagher; M Harber; C Hollon; S Trappe
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

10.  Regulation of Ras-MAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells.

Authors:  Elizabeth R Smith; Jennifer L Smedberg; Malgorzata E Rula; Xiang-Xi Xu
Journal:  J Cell Biol       Date:  2004-02-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.